Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
healthy volunteers/patients
Eribulin
breast neoplasms
,
neoplasms
Eribulin mesylate
ovarian neoplasms
,
ovarian epithelial carcinoma
,
liposarcoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
lymphoma
,
renal insufficiency
,
neoplasms
,
recurrence
,
neoplasm metastasis
,
lung neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
brain neoplasms
,
prostatic neoplasms
,
soft tissue neoplasms
,
residual neoplasm
,
inflammatory breast neoplasms
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
urinary bladder neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
triple negative breast neoplasms
,
sarcoma
,
non-small-cell lung carcinoma
,
breast neoplasms
,
male breast neoplasms
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
Mycophenolate sodium
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
multiple myeloma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
hodgkin disease
,
t-cell lymphoma peripheral
,
myeloid leukemia
,
lymphoid leukemia
Benzimidazole
recurrence
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
prostatic neoplasms
,
neoplasms
Sintilimab
non-small-cell lung carcinoma
,
lung neoplasms
Penpulimab
colorectal neoplasms
,
stomach neoplasms
,
pancreatic neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
squamous cell carcinoma of head and neck
,
large b-cell lymphoma diffuse
,
gastrointestinal neoplasms
,
thyroid neoplasms
,
breast neoplasms
,
recurrence
,
neoplasm metastasis
,
sarcoma
,
rectal neoplasms
,
pheochromocytoma
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
small cell lung carcinoma
,
female genital neoplasms
,
glioblastoma
,
uterine cervical neoplasms
,
neoplasms by histologic type
,
triple negative breast neoplasms
,
male breast neoplasms
,
essential tremor
,
head and neck neoplasms
,
syndrome
,
gastrointestinal diseases
,
digestive system diseases
,
paraganglioma
,
osteosarcoma
,
b-cell lymphoma
,
melanoma
,
esophageal neoplasms
,
adenocarcinoma
,
neoadjuvant therapy
,
immunotherapy
,
neoplasms
,
carcinoma
,
lung neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
lymphoma
,
hodgkin disease
,
squamous cell neoplasms
,
hypersensitivity
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
small cell carcinoma
,
thyroid diseases
Lanifibranor
pharmacokinetics
Gilvetmab
renal cell carcinoma
,
urologic neoplasms
,
carcinoma
,
endometrial neoplasms
,
head and neck neoplasms
,
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
,
small cell carcinoma
,
melanoma
,
squamous cell carcinoma
,
merkel cell carcinoma
,
malignant mesothelioma
,
mesothelioma
,
non-small-cell lung carcinoma
,
lung neoplasms
,
neoplasm metastasis
Enoblituzumab
leukemia
,
non-hodgkin lymphoma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
t-cell lymphoma peripheral
,
lymphoid leukemia
,
parkinson disease
,
tuberculosis
,
healthy volunteers/patients
,
glioblastoma
,
gliosarcoma
,
astrocytoma
,
urologic neoplasms
,
urinary bladder neoplasms
,
urologic diseases
,
urinary bladder diseases
,
cardiovascular diseases
,
dyslipidemias
,
coronary disease
,
acute coronary syndrome
,
obesity
,
metabolic bone diseases
,
breast neoplasms
Efbemalenograstim alfa
neutropenia
,
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
ovarian neoplasms
,
uterine cervical neoplasms
Aglatimagene besadenovec
carcinoma
,
lymphoma
,
triple negative breast neoplasms
,
lung neoplasms
,
pharmacokinetics
,
healthy volunteers/patients
,
pharmacological phenomena
,
breast neoplasms
,
adenocarcinoma
,
neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
uterine cervical neoplasms
,
endometrial neoplasms
,
stomach neoplasms
,
urinary bladder neoplasms
,
small cell lung carcinoma
,
biliary tract neoplasms
,
bone neoplasms
,
bone diseases
,
hereditary sensory and autonomic neuropathies
,
hereditary breast and ovarian cancer syndrome
,
glioma
,
fallopian tube neoplasms
,
astrocytoma
,
head and neck neoplasms
,
dna repair-deficiency disorders
,
sarcoma
,
x-linked bulbo-spinal atrophy
,
neoplasm metastasis
,
recurrence
,
gynecomastia
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
heart failure
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
osteoporosis
,
obesity
,
hepatocellular carcinoma
,
liver neoplasms
Spartalizumab
ovarian neoplasms
,
lung neoplasms
,
neoplasm metastasis
,
kidney neoplasms
,
leukemia
,
myeloid leukemia acute
,
hematologic diseases
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
,
bone marrow diseases
,
syndrome
,
colonic neoplasms
,
rectal neoplasms
,
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
,
glioblastoma
,
multiple myeloma
,
plasma cell neoplasms
,
alveolar soft part sarcoma
,
chordoma
,
neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
colorectal neoplasms
,
carcinoma
,
breast neoplasms
,
renal cell carcinoma
,
pancreatic neoplasms
,
hepatocellular carcinoma
,
lymphoma
,
liver neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
adenocarcinoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
pancreatic ductal carcinoma
,
myelodysplastic syndromes
,
myelomonocytic leukemia chronic
,
ovarian epithelial carcinoma
,
gastrointestinal stromal tumors
,
sarcoma
,
anus neoplasms
,
small cell lung carcinoma
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
prostatic neoplasms
,
large b-cell lymphoma diffuse
,
neuroendocrine tumors
,
urologic neoplasms
,
thyroid neoplasms
,
esophageal neoplasms
,
uterine cervical neoplasms
,
cholangiocarcinoma
,
unknown primary neoplasms
,
adenocarcinoma of lung
,
clear cell adenocarcinoma
,
mesothelioma
,
carcinosarcoma
,
uveal neoplasms
,
adenomyoepithelioma
,
uveal melanoma
,
hematologic neoplasms
,
castration-resistant prostatic neoplasms
,
b-cell lymphoma
,
head and neck neoplasms
,
non-hodgkin lymphoma
,
neuroendocrine carcinoma
,
endometrial neoplasms
,
anaplastic thyroid carcinoma
,
melanoma
,
skin neoplasms
Lenograstim
leukemia
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
neutropenia
,
breast neoplasms
Faropenem
tuberculosis
,
pulmonary tuberculosis
,
otitis media
,
otitis
,
community-acquired pneumonia
,
chronic bronchitis
,
bronchitis
,
acute disease
,
pneumonia
,
bacterial pneumonia
,
community-acquired infections
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use